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Personalized healthcare is expected to increase
the efficiency and the effectiveness of health services
using different kinds of algorithms on existing data.
This approach is currently confronted with the lack
of digital data and the desire for self-determined
personal data handling. However, the issue of health
data donation is on the political agenda of some
governments. Within this work, a knowledge base
will be created by reviewing existing approaches and
technologies regarding this topic with the focus on
chronic diseases. A list of requirements will be derived
from which we conceptualize a data donation cycle to
demonstrate the challenges and opportunities of health
data sovereignty and its future possibilities concerning
data-driven health application development. By linking
the requirements to technological approaches, the
baseline for future open ecosystems will be presented.
1. Introduction and Research Question
Personalized services will play a major role in
future medical care. From today’s perspective,
this data-centered technological development faces
interdisciplinary challenges in the form of ethical,
legal, structural, and economic requirements, but also
technological implications [1]. In addition to a
politically motivated digital sovereignty of individual
citizens, there are the interests of organizations to
profitably incorporate data-hungry algorithms into
products and services that demonstrably provide
benefits for patients and medical professionals to their
individual needs. Questions concerning the collection
and use of digital health data have become the focus of
public attention in recent years. This area of tension is
being rebalanced by the current COVID-19 pandemic.
In general, the use of personal data in medical
applications got more relevant during the pandemic. So
far, it has become visible how complex decisions are
to weigh up the options regarding the use of personal
data through government intervention or voluntary
participation of citizens e.g. the use of the RKI Corona
Data Donation App1 to better understand the current
COVID-19 pandemic in Germany. This illuminates
the challenges in the context of the realization of
data donation to support data-driven development of
medical applications. The interdisciplinary nature
of this topic led to discussions in several fields
and ended at least in ethical, legal, structural,
economic, medical and technological questions [2, 3,
4]. This paper will primarily address the last four
perspectives as implications for self-determined medical
data donation. Therewith, we want to find answers to
the central research question, which requirements and
technological prerequisites are necessary concerning a
sustainable integration of health data in the development
of medical applications. As chronic diseases are one of
the main causes of rising healthcare costs and are seen as
promising to benefit from digital medical applications,
we focus on them [5].
2. Basics
As trust is one of the key factors regarding
the sharing of personal data, trusted infrastructures
are recently discussed as a base for data sharing
in health (see subsection 4.1). Distributed Ledger
Technology (DLT) emerged as a foundation for
trusted infrastructures because of its decentralized and
immutable way of linking transaction data [6]. One
representative of DLT is Blockchain, which links
the transaction histories (blocks) via linked lists to
generate a ledger (chain) so that these are immutable
[7]. For this purpose, each block references the
previous block via the hash code of them. If
a participant with fraudulent intentions changes a
transaction from a previous block, the hashes of all
following blocks change, and the change is recognized
as invalid. Another concept in the context of
service-oriented application development is the use of
containerization technology. To overcome conflicting
or missing dependencies and moving applications and
corresponding from one system to another without
1https://corona-datenspende.de, accessed October 2020





losing executability, the bundling to so-called virtual
containers is used to isolate software, data, libraries, and
configuration files [8]. Using this technology allows
the encapsulation of data and services by ensuring
compatibility and resource-efficient virtualization. To
create interoperability and integration of information
and services, the interdisciplinary research area
Semantic Web emerged [9]. For example, through
semantic annotations using metadata on the Web,
information retrieval can be improved. Semantic
interoperability plays an essential role in the integration
of health data, which is why modern medical data
standards are supported by ontologies defined with
Semantic Web technologies. Health information is one
of the special types of personal data and is therefore
particularly protected by law e.g. the General Data
Protection Regulation (GDPR) in the EU. Therefore,
it may only be collected, stored, used, and processed
under strict conditions e.g. by patient consent or pseudo-
or anonymization. Personal data are considered as
pseudonymous when the data subject can no longer be
identified without the use of additional data, whereas
in the case of anonymous data, the personal reference
is changed to such an extent that the data subject can
no longer be identified [10]. When personal data is
provided, the consent of the patient can be defined by
stating a purpose for data processing. There are different
models of patient consent management and approaches
that allow e.g. the digital mapping of consents by
using Semantic Web technologies, which semantically
describes what can be done with the data, by whom and
in what form [11].
3. Methodology
The following sections describe the research method
and the scientific approach. As research method,
we applied the Design Science Research Methodology
(DSRM) provided by Peffers et al. (see subsection 3.1)
[12]. For getting a broad knowledge base, we applied a
structured literature review (see subsection 3.2).
3.1. Design Science Research
The DSRM aims to develop and evaluate new IT
artifacts in the form of an agile process which iteratively
combines the requirements of the theory with the
practice [12]. The methodology proposed by Peffers et
al. is mainly used for information systems research and
consists of the following six process steps [12] :
(1) Problem identification and motivation; (2) Definition
of objectives of solution; (3) Design and development
of the solution artifact; (4) Demonstration of the
solution artifact; (5) Evaluation of the effectiveness and
efficiency; (6) Communication. The first four sections
of this paper represent step 1 and 2 by explaining
and motivating the research problem and defining the
objectives of the solution artifact. Based on results
of our conducted literature review, requirements and
ideas for a possible solution to our research question
are derived as IT artifacts. The findings, serve as the
foundation for the 3. and 4. step presented as artifacts in
the subsections 4.2. This paper serves as communication
tool for the 6. step of the DSRM and concludes with the
discussion of the results and presentation of connection
points for possible future work linked to step 5.
3.2. Literature Review
In order to identify requirements and approaches
for data donation in the context of chronic diseases,
the following search string was defined for the
structured literature review: “(data OR information OR
knowledge) AND (sharing OR donation) AND health
AND (patient OR personal* OR sovereign OR disease)
AND (mental OR diabetes OR cancer OR dementia
OR oncology)”. With the help of the search string
the following scientific databases were searched to find
publications, which contain these catchwords in their
title, abstract or keywords: IEEE Xplore, ACM Digital
Library, ScienceDirect and EBSCOhost. Through
this search and filtering of duplicates, 740 potentially
relevant publications could be found. Subsequently,
a two-stage manual filtering was carried out by the
authors. In the first step the title, abstract and keywords
were examined in detail to identify relevance to our
research problem. Potentially relevant publications were
then flagged for a more detailed examination of the
full texts, which was part of the second filtering step.
After all 35 publications were marked as relevant. In
addition, their forward and backward references were
taken into account, which led to a total of 47 relevant
publications. These results were cross-validated and the
identified requirements were synthesized among fellow
researchers.
4. Approach
The following section is intended to describe
answers to the defined research question in the form
of artifacts. First, approaches from the literature are
considered in order to derive requirements for a possible
solution. Based on the requirements, we describe
a schematic approach for data-driven development of
medical applications and suitable technologies for an
ecosystem that supports it.
4.1. Approaches from Literature Review
The collection and use of digital health data
is becoming increasingly relevant due to global
developments in the digitization of the healthcare
systems through personal or electronic health records
(PHR or EHR), Internet of Things (IoT) sensors,
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artificial intelligence (AI) and other emerging
technologies [13, 3]. Research on sharing medical
data has been active for several years e.g. Rao et
al. present a software tool called Collaborative Data
Network (CDN) for clinical information sharing
and querying using HL7 standard in 2010 [14, 15].
Nevertheless, there is currently still a lack of uniform
and interoperable infrastructures to gather medical data
for health research and product development that are
available to the general public for participation due to
the fact that many technical, structural, legal and ethical
issues are unresolved [3].
4.1.1. Global Data Donation Efforts
MyHealthRecord2 is the national health record
system of Australia in which patient data is stored
and made available to the citizens. It enables patients
to share health information with doctors, hospitals
and other health care providers. The use and
participation in the system is activated by default for
every Australian and must be actively contradicted.
Data from MyHealthRecord is not yet available for
research purposes, but it is planned. The government is
currently waiting until robust processes and governance,
security, privacy and technical arrangements are in place
[3]. The FINDATA3 authority is the central national
authority for the management and release of health
and social data of the finnish population, which was
introduced by law that came into force in Finland
on May 2019. To this end, it informs researchers
about data availability, issues permits for secondary
use and enables pseudonymized data processing using
their provided secure environments. The access to the
health and social data should be possible in Januar
2021 through the national eHealth infrastructure Kanta4.
23andMe5 is a US biotechnology company which sell
direct-to-consumer genetic tests based on saliva samples
to identify the ancestry and the genetic predispositions
to specific diseases and conditions. The business model
also includes the voluntary possibility to release the test
results combined with web behavior information and
self-reported information to third parties (e.g. academic
institutions or private companies) for research purposes,
commercial applications, patents or operating licenses,
which in return pay money to 23andMe. Due to
this business model and the ethical implications, the
company became the focus of media, politics, science
and even the U.S. Food and Drug Administration (FDA)
[16, 3]. Beside governmental and commercial data
donation approaches there are also scientific ones and
2https://www.myhealthrecord.gov.au/, accessed September 2020
3https://www.findata.fi/, accessed September 2020
4https://www.kanta.fi/, accessed September 2020
5https://www.23andme.com/, accessed September 2020
there seems to be a trend towards more transparency
regarding the communication of research results to
enable further knowledge, research and re-analysis.
However, this also requires the active involvement of
funders and journals, which are currently collecting
research results [17]. Often, incomplete data are
available or the re-use of this data is made difficult,
which leads to financial effects, biases, less benefits
for research and the care of patients [18]. To avoid
these problems Chan et al. make three recommendations
[18]: (1) Academic institutions and funders should
be rewarded for fully sharing their research data; (2)
Legislators, ethics committees, funders and journals
should enforce policies for study registrations and the
availability of full research data; (3) Standards are to
be developed for the content of protocols, full study
reports and data exchange practices. Dugas et al.
present a community-driven multilingual platform for
the exchange and discussion of data models in medical
research and healthcare to improve and accelerate the
design of medical data models by exchanging best
practices and more standardized data models with
semantic annotations [19]. To face the described
problems on national level, the Medical Informatics
Initiative (MII)6 aims to establish an infrastructure for
the integration of clinical data from patient care and
medical research in Germany [20]. This funding is
currently in the development and networking phase, in
which each of the four consortia is setting up a data
integration center in cooperation with the participating
university hospital and partner institutions to develop
IT solutions for specific use cases in different medical
domains [21, 22, 23, 24]. These data integration centres
should first demonstrate how data, information and
knowledge from patient care, clinical and biomedical
research can be linked across the borders of different
locations. At present, these focus on university medical
institutions and do not yet address medical practices,
regional hospitals or patient care in inpatient and
outpatient settings. A research project at European
level provides the project MyHealthMyData (MHMD)7.
The project aims to create the first open biomedical
information network focusing on the link between
organizations and individuals. It wants to encourage
hospitals to start providing anonymized data for open
research and citizens to make the most out of the
available health data and become the owner of their
data. They investigate Blockchain technology as the
key element to connect the healthcare stakeholders and
manage the data sharing process in a proactive, secure,
open and decentralized manner [25, 26]. Therefore,
6https://www.medizininformatik-initiative.de, accessed July 2020
7http://www.myhealthmydata.eu/, accessed July 2020
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they use a federated Blockchain network in which
the authorized participants define the access control
policies in terms of the Blockchain. An off-chain
approach is used for health data storage to maintain
GDPR compliance, since only references to the data
via hash values are stored in the Blockchain and
the sensitive health data does not leave its storage
facilities [25, 26]. This off-chain approach is discussed
and used in the healthcare context by several other
identified publications [27, 28, 13, 29]. In the MHMD
solution, the various participants in the network prove
their identity through certificates issued by a certificate
authority. After the data has been fed into the network
by the data owner, a data consumer can request the data
based on these certificates. Combined with user-defined
consent settings, a data owner can manage and authorize
data exchange and access to their own health data to get
the opportunity to track, who has used the data, when
and under which condition. The data can be found
by the data consumers using metadata summarized
in a central catalogue. Gordon et al. [29] discuss
the challenges and limitations for facilitating the use
of Blockchain technology in healthcare services. In
particular, the topics of scalability, creation of incentives
for the further development and maintenance of the
interoperability solution, patient key management and
patient engagement need to be addressed. To ensure
privacy-by-design harmonization tools, encryption and
de-identification technologies are combined with the
MHMD solution [25, 26]. The overall objective
of MHMD is to create a trustworthy information
marketplace that offers added value to citizens,
hospitals, research centres and businesses. Jaremko et
al. address the trust issue regarding data transfer and
processing as well as regarding the data consumer, by
processing the data completely anonymously and only
for the intended purposes also by envisaging Blockchain
technologies in combination with containerization as
well as validated methods for the de-identification of
data [30].
4.1.2. Data Sharing for Personalized Medicine
Further challenges of embedding data sharing
solutions in scientific, medical and patient settings
are seen in ethical, legal and regulatory questions by
Lawler et al. [4]. They consider in particular, data
sharing for the combination of clinical and genomic
data as an important aspect for personalized medicine
and cancer research, but see genomic data as hard
to anonymize. The study of Pickard examined how
financial compensation affects the willingness to share
health data [31]. Two thirds of the participants
would be more motivated to share the information
through a financial reward. The possibility of
gaining more insight into current state of health of
an individual and more self-determination as well as
opportunities for participation in the treatment process
could be a motivation, especially for people suffering
from chronic diseases [32]. When managing their
chronic disease, affected people are confronted with
the continuous recording and management of their
conditional data. Patient-centered self-management
applications are particularly important for improving
the diagnosis and treatment of chronic diseases because
they enable remote data collection and monitoring
[5]. Herewith, those applications should handle
the sensitive data safe from scratch in order to
guarantee general security and privacy. Accordingly,
Al-Taee et al. identify security requirements needed
to build up a solution for enhancing security and
personal privacy in mobile health systems [33]. The
main focus of the solution is the use of data
protection mechanisms, cryptographic methods, access
control and auditable procedures that give patients
and healthcare professionals the right to control the
disclosure of identifiable health data in this case.
Further self-management systems (SMS) and assistive
technologies with the aim of supporting patients with
different chronic diseases like diabetes [5], serious
mental illness [34] and dementia [35] could be
determined. The continuous and frequent monitoring
of longitudinal data in outpatient home environments,
which provides the basis for analysis, is often not
yet available to healthcare providers or research [36].
Ma et al. present an open source cloud platform for
the exchange of health data and support for outpatient
chronic disease care [37]. Especially, the aspects
interoperability, security and privacy are identified as
the key challenges to effectively exchange health data.
Hu et al. introduced a hybrid cloud-based solution
to share the data collected in this environment with
healthcare provider via a private cloud as well as with
third party health services and researchers via a public
cloud to promote the treatment of chronic diseases [36].
The willingness to provide patient-generated data to
research and central registers depends on whether it
is possible to receive information and knowledge in
return. In a study among cancer survivors, Smith et
al. found that the participants were willing to exchange
information on the long-term effects and treatment
of cancer, but expressed the wish to receive further
evidence based information from the central registries,
which could be helpful for their self-management and
shared care beyond the cancer [38, 39]. As SMS
come along with the cognitive intake of large amounts
of health information and communication with health
care providers to empower informed decisions, both
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need visual tools to simplify and manage complex
information [40]. Rajwan et al. provide a guideline
for the design and implementation of such visualizations
[40]. The study of O’Kane et al. found that there
were discrepancies between the information needs of
patients and clinicians [41]. Clinicians are mostly
interested in the data itself and the needs of the patient.
In contrast, patients want to get knowledge from the
available data to better monitor and understand their
health condition. Accordingly, the visualization must be
adapted to these needs. In addition to the visualization,
the entire data exchange and donation process must
correspond to the data owners consent appropriate
to data protection regulations which is why consent
management is necessary. O’Kane et al. showed that
consent decisions to share data change over the course
of a lifetime, depending on the ever-changing health
status and technological experience [42]. According
to them, the possibility of modifying a given consent
with regard to the patient’s own current data protection
sensitivity should be taken into account. The study of
Grando et al. reviews patients and behavioral health
providers opinions about consent preferences and the
desired granularity when exchanging behavioral health
data for care or research [43]. That study concludes that
patients want granular consent control. However, from
the provider’s point of view, patients should be trained
to make such decisions informed.
4.1.3. Shared Decision-Making
Currently, Odisho and Gore see shared
decision-making between patient and healthcare
providers based on data as blocked by the patients
significant knowledge-barriers which impairs the ability
to be an effective part of their own care process [44].
They propose a structured approach for patient-centered
health information to help patients to obtain and
better understand it. Jourquin et al. see inclusion and
transfer of control to the patient himself as challenges
for better, optimized therapy decisions [45]. These
challenges face opportunities which are seen in the
development and implementation of decision support
systems (DSS) to enable personalized medical treatment
[46, 47, 48]. Based on health-related data, decisions
can be made using technological advancements and
methods to support the process of these enormous
amounts of data profitably. Wang et al. present a
shared decision making framework which uses EHR
data to provide a list of possible diabetes medication
using a classification model, which should serve
as the basis for the consultation between physician
and patient [47]. Goletsis et al. present a decision
support platform based on clustering techniques that
identify patients with similar clinical characteristics
and genetic predisposition [46]. They use their results
to choose a personalized treatment plan based on the
assumption that patients with a similar profile have a
similar treatment plan. Semantic information, which
is described using ontologies, serves as input for the
clustering methods. Sqalli et al. present an conceptual
AI-supported health coaching model and process that
aims to support the patient in the long-term management
of his chronic disease by producing personalized
health plans using sensor data, machine learning and
visualization tools [48]. Krithara et al. are building a big
data system for decision makers which combines data
from clinical notes, genomics, EHR and bibliography to
identify patterns that help to adapt public health policies
and individual diagnosis and treatment strategies for
dementia and lung cancer [49]. Suinesiaputra et al.
show how the sharing and open access to data are
important for advancing the understanding of the heart
functioning to find better ways to stop the progression
and therapeutics concerning heart-related disease [50].
Within this context, Seth et al. use data from Body
Sensor Networks (BSN) to model cardiac functioning
for personalized medicine [51]. To build these kinds of
DSS, Li et al. note that a large amount of data is needed
from different healthcare facilities to train decision
models. But according to Jaremko et al., due to the
sensitivity of data, privacy rights must be given priority
so that AI methods must be adapted to be functionally
safe, understandable and avoid black boxing [52, 30].
4.1.4. Security and Privacy
Sajedi et al. review algorithms like cryptography,
watermarking and steganography and their application
in health information systems [53]. They recognize
the trade-off between hiding and analyzing information
and describe the challenges of security in healthcare
systems. Addressing the privacy challenge, Li et
al. present two distributed privacy-preserving ensemble
approaches that can be used without disclosing sensitive
patient-level data by first learning the data distribution
from the facilities and then sharing and combining these
local models into integrated data models [52]. Paddock
et al. could prove that by means of homomorphic
encrypted data can support real-time learning in
personalized cancer medicine, as it allows analysis of
the data while keeping it encrypted at all times [54].
According to them, homomorphic encryption does not
neglect all privacy concerns, especially with respect to
de-identification, since it is possible e.g. to identify
individuals even from pooled samples of genomic data.
Shahbaz et al. propose an anonymity algorithm for
DICOM images and textual patient and communication
information to ensure privacy and security of the data
using a cloud-based system [55]. The anonymization
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is combined with an access policy so that it is applied
according to the role of the user. The solution of a
flexible, standards-based, privacy-enhanced user profile
management approach based on an adaptive extended
merkle structure from Sánchez-Guerrero et al. enable
the patient to selectively disclose identity information
and protect their privacy [10]. Those approaches can
reduce the perception of privacy risks and highlight
the benefits for individuals, which seems, besides
accountability and conditionality, an important aspect to
build up health data frameworks [56].
4.2. Requirements in Data Donation Cycles
The iterative development of medical applications
enables a continuous integration of new data into the
development process. These steps result in products,
services or procedures, which in turn generate new
data that can be used for continuous improvement
of existing solutions or to enable the development
of innovative approaches by combining different data
sources. This is what we call data-driven development,
which results in a cyclical approach that requires the
consideration of the derived requirements based on
the identified approaches outlined in Table 1. This
shows the challenges, that must be considered from
different points of view. Figure 1 outlines such a data
donation cycle schematically. The data owner needs
the possibility to request the data from the collecting
and storing parties and to determine himself which data
is passed on to third parties, who have access, and
what may be done with it (S1,S1.1,S2). This requires
a tool for visualization and administration of existing
health data by the data owner itself, which is designed
in a user-friendly way (T3). A research-compatible
cross-institutional electronic health record could provide
data adapted to the needs of health professionals
and clinical researchers (M1) to best support decision
making and enhance the patient’s understanding of his
or her health status (M3). In addition to the quality
of this data (T5), the mapping and forwarding of the
data in a internationally recognized standard play a
role (T6.5). Semantic interoperability can be ensured
through standardized descriptions of these resources and
prevents lock-in effects (T6.3,T6.1,T6.2). Besides, it
must be ensured that not only data but also processes,
the identities and access rights linked to them are
inter-organizational interoperable (S1.2). Technological
approaches for this are seen in the application of DLT
[25, 26, 27, 28, 13, 29]. Besides a possible legal fixation
of this necessity for manufacturers, this additional effort
must be balanced by compensation mechanisms for
researchers and research projects (E2). The collected
data itself can either be made available free of charge
(philanthropic approach) (S3) or by providing services
or monetary values in return (capitalistic approach)
(E1). Anonymization can make entire health data
histories available for research even after death (S3.1),
or individual data sets which, in combination with
others, provide a holistic view of a specific medical
condition. Pseudonymization allows the continuous
collection and monitoring of longitudinal data (S3.3) but
requires the secure administration of the true identity
by the data owner himself or by a data custodian. In
this case, personal data are involved, which may make
it legally necessary to specify a purpose concerning the
data processing, i.e. by whom and for what the data
may be used (S2.1). This consent should be digitally
available and therefore in an automatically processable
electronic format (see section 2). Here, trust and thus
transparency must be guaranteed that the data is used
exclusively for the purposes specified (S2.2). A further
advantage of pseudonymization is the possibility to
request further data for studies if the persons concerned
have explicitly agreed to be contacted (S4.1,S4.2).
The combination of health data, their metadata, and
consent can be encapsulated by containerization to
ensure integrity (T2.3) and traceability of the data
processing steps. These data capsules can be kept either
by the collecting agency, the data owner himself or
a data custodian. The capsules themselves may have
logic that implements transparent access control and
validation mechanisms in combination with a trusted
infrastructure. To release the data to other interested
parties, a decentralized register can be created, making
the data discoverable (S4.3,T4). The storage of the
data itself should be decentralized as well (T7) but high
availability must be guaranteed (T2.4). Information
about the correctness of the data (T2.2) by the data
originator as well as releases can also be mapped in
the form of manipulation-proof access rights (T1.4) to
trusted actors (T1.5) in a decentralized and distributed
register. Authorized organizations (T1.5), with interest
and competence in generating added value from the
data, can contribute to the development processes by
combining existing data sets while complying with data
protection and security requirements (T2,T6,T6.4,T6.3).
Using flexible (T11), expandable (T12), privacy and
confidentiality preserving (T1, T2.5) data analytics
tools, epidemiological predictions can be made in
real-time (T8, T10) or new insights can be gained to
support healthcare (T9). It must be kept transparent
and persistent what the data capsules were used for
and to what extent new findings can be traced back to
them (S2.3,S4,T2.5). This information must be made
available to the data owner (S3.2). The new findings are
used as artifacts in the development of new treatment







S1 - Sharing of health data: The sharing of health data across institutional boundaries (e.g. between medical institutions,
family members) [21, 25, 24, 22, 20, 3, 23, 50, 32, 43, 37, 52, 13, 42, 56, 10, 14, 15, 29, 36, 45].
S1.1 - Release of data to third parties: The possibility of sharing the donated data with commercial user groups
(e.g. university spin-offs, start-ups) in order to promote innovation e.g. in the field of analysis and artificial
intelligence [30, 28].
S1.2 - Organizational interoperability: Support of cross-system processes, identities and rights [21, 20, 29].
S2 - Data governance: Patients gain access and control over their health data, allowing them to monitor the current and
clinically correct data stored about them. The patient has the power to manage any exchange of data by defining the exact
content, purpose and access rights (patients’ right of informational self-determination) [21, 25, 26, 41, 24, 20, 3, 23, 28,
44, 32, 39, 33, 48, 29, 45].
S2.1 - Consent management: Medical data may be processed only if the data owner has given his consent. The data
owner has the right to revoke his consent at any time [21, 25, 26, 24, 22, 20, 3, 28, 50, 51, 43, 37, 17, 42, 56, 10, 38,
17, 29].
S2.2 - Trustworthiness: As a data owner who makes his data available via a platform, trust must prevail. On the one
hand, technologically in the data sharing and storing environment, but also in the other participants involved so that
they do not do anything with the data that is contrary to the will of the data owner. In contrast, a data consumer must
be able to trust that the data is trustworthy and correct. This trust must be noticeable [21, 26, 24, 3, 23, 28, 49, 32,
43, 37, 30, 4, 42, 54, 10, 29, 36].
S2.3 - Traceability of the data life cycle: The data owner can view his health data and the history of all actions (e.g.
access, use in research and clinical studies) on this data as well as the corresponding identities and the purpose behind
that actions to track the entire data life cycle [25, 26, 20, 3, 23, 53, 27, 34, 45].
S3 - Data donation for research: The possibility of selectively releasing one’s own health data should exist so that data
owners can find possible research projects and studies to support them with their data. Here, the data owner should be
able to actively decide via informed consent whether to donate, what to donate and to whom [3, 21, 22, 24, 23, 50, 18, 51,
19, 43, 37, 30, 17, 4, 42, 38, 45].
S3.1 - Post mortem data donation: Patients should have the opportunity to donate their medical data for research
purposes after their death, similar to organ donation [57].
S3.2 - Sharing of research results: Feedback of research results back to data owners and patients with similar
diseases and symptoms [18, 30, 38, 36].
S3.3 - Monitoring of patient-generated longitudinal data: Support and integration of mobile patient applications
and IoT devices to collect, share and monitor patient-generated data, such as vital parameters, physical activities,
nutritional intake and individual assessments and descriptions of the patient’s own well-being [21, 41, 3, 5, 50, 32,
53, 37, 27, 33, 13, 48, 54, 56, 10, 38, 34, 29, 36, 45].
S4 - Transparency and reproducibility of research results: The sharing of the corresponding research data (metadata,
source code, variable definitions, de-identified data) with cost bearers of research projects, journals that publish
the scientific publications and the public through accessible data repositories. Transparent documentation about the
methodology and procedures used to collect the data to keep records about the whole process and possibilities to reuse
the research data [17, 45].
S4.1 - Request for use in research: For a specific research project, the health data of a patient can be made available
to the requesting partner based on the patient consent [21, 24, 20, 3, 18, 30, 42, 14]. For data requests, the type and
purpose of data processing by the data consumer must be specified [26, 23].
S4.2 - Secondary use of medical research data: Provide medical research data for secondary use and analysis of
the data by further researchers and studies [57, 24, 30, 17, 4, 42, 54, 34].
S4.3 - Prior registration of studies: Registration of research studies including the indication of intended analyses






al E1 - Perceivable benefits of data donation: The data donor receives compensation in the form of monetary or service
benefits (e.g. via crypto token) by releasing his personal health data or research results to data consumers [28, 43, 30, 17,
4, 16].
E2 - Funding research data preparation and sharing: Funding of researchers and research projects to compensate the






T1 - Data privacy: Ensuring data privacy of patients and probands according to national regulations during the storage
and transmission of data through privacy-by-design architecture [25, 57, 24, 21, 31, 26, 22, 3, 5, 23, 28, 49, 50, 18, 51,
32, 43, 53, 58, 37, 30, 45, 27, 4, 52, 33, 13, 42, 54, 56, 10, 14, 15, 55, 34, 29, 36]. Prevent data loss and data leakage
[26, 28, 30].
T1.1 - Data deletion: Deletion of the stored data by the data owner [30, 25, 5].
T1.2 - De-identification: Possibility to remove direct identifying information from the medical data via
anonymization or pseudonymization [21, 31, 26, 24, 22, 20, 23, 28, 50, 18, 51, 58, 30, 42, 54, 10, 15, 55, 29, 46, 45].
T1.3 - Privacy preserving analytics: Support for privacy preserving analysis algorithms (e.g. privacy preserving
smart contracts, secure multi-party computation, zero-knowledge, homomorphic encryption [25, 54], distributed
computing, DataSHIELD, containerzation [30]) so that data does not have to leave its local storage facility, because
the algorithms are brought to the data [21, 26, 24, 22, 30, 4, 52, 42, 54, 55]. The algorithms should be functionally
safe, understandable and avoid black boxing [30].
T1.4 - Usage and access management: Fine-grained definition, monitoring and control of access to health data by
the data owner. Compliance should be controllable. Access and the purpose of use should be documented and
authorised by the data owner for a specified period of time [21, 24, 22, 20, 5, 23, 43, 53, 27, 33, 13, 42, 54, 10, 14,
15, 55, 38, 29].
T1.5 - Users authentication and authorization: Enable authentication of user (e.g. using a single sign-on approach,
two-factor authentication) or user devices in order to be able to view the health data and to distribute, maintain and
verify usage and access rights [26, 24, 22, 20, 23, 27, 33, 10, 15, 55, 29].
T2 - Security: Apply the security-by-design approach to system design, implementation and operation [25, 21, 26, 24,
22, 20, 5, 23, 28, 50, 51, 32, 43, 53, 37, 30, 45, 27, 4, 33, 13, 42, 54, 56, 10, 14, 15, 55, 29, 36].
T2.1 - Data obfuscation: Obfuscation of data via encryption, digital watermarks or steganography to ensure data
security and confidentiality [5, 25, 57, 26, 28, 53, 37, 27, 33, 54, 10, 14, 29].
T2.2 - Data accuracy: Guarantee the correctness of the data [32].
T2.3 - Data immutability: Verification of the immutability of the data to build trust [25, 28, 30, 27, 13, 29, 26].
T2.4 - Availability: The (permanent) availability of data for all authorized actors [53, 37, 43, 50, 33, 13, 55, 45].







T3 - Usability: User-friendly and patient-centered tools for visualizing and managing existing health data and access
rights. The entry hurdle for non-technical users should be low in order to increase acceptance for use [21, 22, 5, 44, 43,
48, 40, 14, 29, 46, 45].
T4 - Data identifier: Provision of machine-processable description, data catalogue or data tags, which represents the
aggregated metadata of the available data to enable the searches and data requests for data [26, 22, 20, 3, 23, 28, 54].
T5 - Data quality: Measurement and documentation of data quality in its original state and along the data life cycle also
in aggregated form [24, 22, 3, 5, 28, 45].
T6 - Sustainability: Express data in technology-neutral and open formats so that data and its definitions can be efficiently
migrated from one technology stack to another [21, 22, 23, 17].
T6.1 - Domain-driven data modeling: Involvement of domain specialists (e.g. researchers, healthcare
professionals) in the data modelling and the seperation between the technical implementation details from domain
modeling [21, 24].
T6.2 - Avoidance of vendor lock-in: The choice of standards, frameworks and system components so that vendor
lock-ins are avoided, e.g. by preferring open source software, standards, models, frameworks and specifications
[21, 24, 3, 22, 15].
T6.3 - Semantic interoperability: Use internationally recognized, proven and open-technology terminologies and
standards (e.g. HL7 FHIR, DICOM, IHE, openEHR, SNOMED CT) to enable communication between different
systems [21, 24, 20, 23, 49, 50, 19, 37, 10, 14, 15, 46].
T6.4 - Data aggregation and harmonization: Building a common understanding of information and data from
different data silos by merging the different data types and building consistent data through computable semantic
models (e.g. ontologies) [21, 46, 52, 14, 15, 29, 45, 24, 22, 49, 50, 19].
T6.5 - Structural interoperability: Enable data flows between different systems and data silos [21, 22, 24, 20, 5,
23, 37, 29, 45].
T7 - Decentralization: Decentralized storage of the data where they were generated. In case of necessary data transfer,
the data will not leave the local data storage facilities without the consent of the data owner [21, 24, 23].
T8 - Predictive analytics: Use of analysis and clustering methods for predicting or identifying patterns and connections
between patients, their disease courses and findings to be able to make early decisions regarding diagnosis and treatments.
[21, 49, 24, 22, 23, 50, 51, 37, 30, 48, 54, 46].
T9 - Data enrichment: Analysis of aggregated data (e.g. using Natural Language Processing (NLP), ontological
annotations or machine learning techniques) to extract meaningful knowledge in a structured form [21, 22, 23, 49, 51].
T10 - Scalability and performance: Possibility for handling and processing a large amount of complex and constantly
changing data [21, 24, 22, 5, 50, 51, 14, 36].
T11 - Flexibility: A data analytics infrastructure should guarantee a high degree of flexibility in order to support different
configuration and further processing options of the data according to the application (e.g. support of different file formats
for export) [21, 10].
T12 - Extensibility: The IT architecture should be modular and expandable, so that a multitude of use cases can be served





M1 - Clinical relevance: The data that can be entered and made available though a platform or donation are adapted to
the needs of healthcare professionals and clinical researchers. The information and services should be prepared in such a
way that those groups of people are supported according to the clinical use case [21, 41, 3, 49, 44, 47].
M2 - Data-driven personalized medicine: Improvement of patient care, especially therapy and diagnostics due to an
increased amount of data. The aim is to design therapies as individually and precisely as possible for patients and to
return possible findings to the patients [24, 22, 3, 28, 49, 50, 51, 39, 37, 30, 27, 35, 4, 48, 56, 38, 34, 46, 45].
M3 - Support collaborative decision making: Provision of historical patient and study data, as well as the necessary
background knowledge in a visually adapted form for patients, medical staff and clinical research to best support decision
making and to strengthen a patient’s understanding about their own condition. [21, 41, 3, 5, 44, 32, 27, 33, 48, 40, 46, 47].
Table 1: Identified Requirements for Data-driven Development of Medical Applications.
services (S1.1), which in turn generate new data whose
effects must be analyzed.
5. Discussion and Future Work
Through a structured literature review, we
identified requirements for self-determined health
data management to embed them in a value-added data
donation cycle. Currently, most approaches focus on
enabling data-driven medical research for personalized
medicine. The technological approaches outlined above
could show a way to open data silos for data-driven
medical application development to external actors
such as companies. However, the approaches found are
subject to national legislation and cultural influences
about the willingness to make personal health data
available. To address this interdisciplinary problem, we
showed that not only technological but also structural,
political, ethical, economic, and legal aspects must be
resolved as well as compromises must be found for the
development of a suitable open ecosystem. The derived
requirements are based exclusively on the literature
found by the review and depend strongly on the selected
search string. Accordingly, further requirements can be
found and are not limited to those mentioned here.
In the future, our research will continue to focus on
the technological feasibility of the described data
mobility mechanisms and their implications from
different stakeholder perspectives. In particular,
the self-determined control of decentralized health
data flows and the privacy-preserving traceability of
data analytics steps represent profound technological




























































Figure 1: Schematic Data Donation Cycle.
based on a use case, which illustrates the cycle described
above and makes it possible to verify it in real world
scenarios.
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